Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T22:29:54.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal layout, replacing the previous study-record content and navigation. This indicates the page is currently inaccessible due to permissions.
    Difference
    20%
    Check dated 2026-09-20T22:25:36.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    There are no textual additions or deletions recorded for this page in the provided data.
    Difference
    0.1%
    Check dated 2026-09-13T20:42:12.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    No textual changes were detected for this page. The current content remains as shown in the provided context.
    Difference
    0.2%
    Check dated 2026-09-06T22:28:51.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, signaling a newer version of the page. This reflects a backend or presentation update rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-08-30T21:54:19.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    No changes were detected in the study details text based on the provided data.
    Difference
    0.1%
    Check dated 2026-08-23T19:01:46.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.